Everything you need to know about the latest CSL dividend

Own CSL shares? Here's the details regarding its latest dividend.

| More on:
Two happy scientists analysing test results.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL shares dip 1.24% to $292.73 during early afternoon trade following the company's FY22 results 
  • The board announced a final dividend of US$1.18 per share 
  • Eligible shareholders will receive payment on 5 October 

The CSL Limited (ASX: CSL) share price is backtracking 1.24% to $292.73 today following the release of the company's full-year results.

The biotherapeutics company reported a mixed performance due to a "difficult global environment."

Nonetheless, the result was in line with expectations, achieving the top end of its guidance.

Here's a look at the CSL's latest dividend that was announced to the market.

CSL maintains full-year dividend

After delivering a net profit after tax (NPAT) of $2,255 million in FY22, the CSL board declared a final dividend of US$1.18 per share.

When converted to the Australian currency, this reflects an approximate dividend of $1.68 per share, franked at 10%.

Moreover, despite CSL maintaining its full-year dividend of US$2.22 apiece, this is 6% higher due to favourable currency movements.

The full-year dividend is equivalent to 46.2% of the group's basic earnings per share (EPS) of US$4.81.

You still have time to scoop up the latest dividend as the ex-dividend date falls on 6 September.

CSL will pay the distribution of its profits to eligible shareholders on 5 October.

What about the FY23 dividend?

While CSL didn't give any guidance on its dividend for FY23, we take a look at what Goldman Sachs had to say.

The broker released its key takeaways on the back of CSL's FY22 results.

It said "NPAT is guided to $2.4bn-2.5bn, excluding Vifor (constant currency terms). Consensus expectations are heavily distorted by the impact of Vifor in our view, but our best guess at 'organic CSL' consensus is $2.575bn."

Upside risks included: More supportive pricing dynamic than we already expect, positive results from pipeline/pre-commercialisation products, and plasma donor fee deflation.

However, downside risks involved: Competitive product launches, challenges associated with unemployment/payer mix, and sustained challenges due to COVID-19.

Goldman Sachs has a neutral rating on CSL with a 12-month target price of $307 per share.

CSL share price snapshot

Over the last 12 months, the CSL share price experienced volatility on the back of an uncertain global economic outlook.

After touching a 52-week low of $240.10 on 15 February, its shares hit resistance at around the $270 mark.

Since then, that barrier has been breached with CSL shares trading around 4% under the psychological $300 level.

Based on today's price, CSL commands a market capitalisation of $141 billion and has a trailing dividend yield of 1.03%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

A women cheers with clenched fists having read some good news on her laptop.
Dividend Investing

3 excellent ASX dividend shares to buy now

Analysts say that these shares are in the buy zone right now for income investors.

Read more »

Woman relaxing on her phone on her couch, symbolising passive income.
Dividend Investing

Here's how much passive income I'd get if I invested $20,000 in Westpac shares now

A $20,000 investment in Westpac shares could deliver some welcome additional passive income.

Read more »

Three women cruise along enjoying ice-creams in the sunshine.
Dividend Investing

Passive income powerhouses! 3 ASX shares I'd consider buying for rising dividends

Here are three ASX dividend shares that I think are worth considering today.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Dividend Investing

Invest $10,000 in this ASX dividend stock for $550 per year in passive income

Big returns and passive income could be on the cards for investors according to Morgans.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

Buy BHP and these ASX dividend shares

Analysts think these income options would be great picks this month.

Read more »

a man sits at his computer screen scrolling with his fingers with a satisfied smile on his face as though he is very content with the news he is receiving.
Dividend Investing

Buy these excellent ASX 200 dividend shares for very juicy yields

Income investors might want to check out these buy-rated shares according to analysts.

Read more »

Happy woman holding $50 Australian notes
Dividend Investing

10 ASX shares that have raised dividends for a decade

Here's the list of 10 ASX dividend shares with an unbeatable track record.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Dividend Investing

2 ASX dividend shares offering over 5% yield

Grab a cuppa, get comfy, and let’s dive into the exciting world of dividends Down Under.

Read more »